Danaher Corporation (DHR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Danaher Corporation (DHR) has a cash flow conversion efficiency ratio of 0.033x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.66 Billion) by net assets ($51.07 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DHR stock market capitalisation for the company's overall valuation and market capitalisation.
Danaher Corporation - Cash Flow Conversion Efficiency Trend (1990–2024)
This chart illustrates how Danaher Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Danaher Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Danaher Corporation ranked by their cash flow conversion efficiency. Explore cash flow quality index of Danaher Corporation to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shandong Zhongji Electrical Equipment Co Ltd
SHE:300308
|
0.059x |
|
Pfizer Inc
NYSE:PFE
|
0.010x |
|
Deutsche Telekom AG
XETRA:DTE
|
0.117x |
|
The Boeing Company
NYSE:BA
|
-0.030x |
|
Novo Nordisk A/S
CO:NOVO-B
|
0.039x |
|
Banco Santander S.A
F:BSDK
|
0.080x |
|
Pfizer Inc
SA:PFIZ34
|
0.010x |
|
Welltower Inc
NYSE:WELL
|
0.015x |
Annual Cash Flow Conversion Efficiency for Danaher Corporation (1990–2024)
The table below shows the annual cash flow conversion efficiency of Danaher Corporation from 1990 to 2024. View DHR live share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $49.55 Billion | $6.69 Billion | 0.135x | +0.78% |
| 2023-12-31 | $53.49 Billion | $7.16 Billion | 0.134x | -21.25% |
| 2022-12-31 | $50.09 Billion | $8.52 Billion | 0.170x | -8.07% |
| 2021-12-31 | $45.18 Billion | $8.36 Billion | 0.185x | +18.54% |
| 2020-12-31 | $39.78 Billion | $6.21 Billion | 0.156x | +19.60% |
| 2019-12-31 | $30.28 Billion | $3.95 Billion | 0.130x | -8.42% |
| 2018-12-31 | $28.23 Billion | $4.02 Billion | 0.142x | +8.03% |
| 2017-12-31 | $26.37 Billion | $3.48 Billion | 0.132x | -13.57% |
| 2016-12-31 | $23.08 Billion | $3.52 Billion | 0.153x | -4.61% |
| 2015-12-31 | $23.76 Billion | $3.80 Billion | 0.160x | -0.18% |
| 2014-12-31 | $23.45 Billion | $3.76 Billion | 0.160x | +0.36% |
| 2013-12-31 | $22.45 Billion | $3.59 Billion | 0.160x | -10.76% |
| 2012-12-31 | $19.08 Billion | $3.42 Billion | 0.179x | +15.64% |
| 2011-12-31 | $16.97 Billion | $2.63 Billion | 0.155x | +2.25% |
| 2010-12-31 | $13.77 Billion | $2.08 Billion | 0.151x | -2.26% |
| 2009-12-31 | $11.63 Billion | $1.80 Billion | 0.155x | -18.30% |
| 2008-12-31 | $9.81 Billion | $1.86 Billion | 0.190x | +4.63% |
| 2007-12-31 | $9.09 Billion | $1.65 Billion | 0.181x | -22.21% |
| 2006-12-31 | $6.64 Billion | $1.55 Billion | 0.233x | -1.73% |
| 2005-12-31 | $5.08 Billion | $1.20 Billion | 0.237x | +5.95% |
| 2004-12-31 | $4.62 Billion | $1.03 Billion | 0.224x | -5.33% |
| 2003-12-31 | $3.65 Billion | $861.54 Million | 0.236x | +0.10% |
| 2002-12-31 | $3.01 Billion | $710.35 Million | 0.236x | -13.55% |
| 2001-12-31 | $2.23 Billion | $608.47 Million | 0.273x | +3.53% |
| 2000-12-31 | $1.94 Billion | $512.25 Million | 0.264x | +7.53% |
| 1999-12-31 | $1.71 Billion | $419.10 Million | 0.245x | +0.07% |
| 1998-12-31 | $1.35 Billion | $331.30 Million | 0.245x | -19.28% |
| 1997-12-31 | $916.90 Million | $278.40 Million | 0.304x | +11.93% |
| 1996-12-31 | $800.30 Million | $217.10 Million | 0.271x | -8.70% |
| 1995-12-31 | $586.30 Million | $174.20 Million | 0.297x | -2.04% |
| 1994-12-31 | $476.10 Million | $144.40 Million | 0.303x | -18.77% |
| 1993-12-31 | $363.70 Million | $135.80 Million | 0.373x | +78.45% |
| 1992-12-31 | $348.40 Million | $72.90 Million | 0.209x | +59.84% |
| 1991-12-31 | $319.30 Million | $41.80 Million | 0.131x | -42.96% |
| 1990-12-31 | $305.00 Million | $70.00 Million | 0.230x | -- |
About Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the deve… Read more